A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing. Swiss ...

An experimental antibiotic, zosurabalpin, to fight a deadly superbug has entered the final human trials. Currently, no new antibiotics targeting this superbug have been developed in over five decades.

“Often when people come to us, it's with test results that indicate an infection caused by bacteria that has some level of ...

A large observational study provides evidence that antibiotics provide no benefit for patients hospitalized with nonsevere ...

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...

The antibiotic can no longer be used in moderate acne vulgaris, eradication of Helicobacter pylori, and prevention of ...

A study finds that repeated early antibiotic exposure in premature infants is associated with poor lung function and an ...